Among these downregulated mitochondrial circRNAs, circRNA ATP5B regulator ameliorates NASH by suppressing fibroblast activation and the output of mitochondrial ROS, which is mediated by PGC-1α and interacted with ATP5B. Here, ATP5F1B is linked to metabolic dysfunction-associated steatohepatitis.